<DOC>
<DOCNO>
EP-0014590
</DOCNO>
<TEXT>
<DATE>
19800820
</DATE>
<IPC-CLASSIFICATIONS>
A61P-31/06 A61P-37/00 A61P-31/00 C07D-277/80 C07D-277/82 A61K-31/428 C07D-277/00 
</IPC-CLASSIFICATIONS>
<TITLE>
crystalline forms of n-2-(6-methoxy)benzothiazolyl-n'-phenyl urea and process for their preparation.
</TITLE>
<APPLICANT>
lilly co elius<sep>eli lilly and company<sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us <sep>
</APPLICANT>
<INVENTOR>
lappas lewis christopherus  <sep>lorenz leslie johnus<sep>wikel james howardus<sep>lappas, lewis christopher<sep>lorenz, leslie john<sep>wikel, james howard<sep>lappas, lewis christopher5331 hawthorne driveindianapolis, indianaus<sep>lorenz, leslie john1020 west 58th streetindianapolis, indianaus<sep>wikel, james howard4068 sunshine waygreenwood, indianaus<sep>
</INVENTOR>
<ABSTRACT>
crystalline monohydrate (form iii) and anhydrate (form  iv) of n-2- (6-methoxy)benzothiazolyl -nâ€²-phenylurea  (frentizole) are described herein, which are stable, have a  greater bulk density, are less electrostatic and are more freely  flowing than previous crystalline forms.  
</ABSTRACT>
</TEXT>
</DOC>
